Jeil Pharmaceutical Co Ltd (271980) — Long-term Investment Intensity
Jeil Pharmaceutical Co Ltd (271980) has a Long-term Investment Intensity of 0.2% as of September 2019. Long-term investments of ₩962.66 Million represent 0.2% of total assets of ₩401.59 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See 271980 total equity for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Jeil Pharmaceutical Co Ltd Long-term Investment Intensity (2017–2018)
This chart shows how Jeil Pharmaceutical Co Ltd's Long-term Investment Intensity has evolved across 2 annual periods from 2017 to 2018. As of September 2019, the intensity stands at 0.2%, reflecting long-term investments of ₩962.66 Million against total assets of ₩401.59 Billion KRW. Also explore Jeil Pharmaceutical Co Ltd balance sheet assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Jeil Pharmaceutical Co Ltd (2017–2018)
The table below presents the year-by-year Long-term Investment Intensity for Jeil Pharmaceutical Co Ltd from 2017 to 2018, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see 271980 market cap.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 0.2% | ₩977.95 Million | ₩402.90 Billion | ▼ -0.5 pp |
| 2017 | 0.7% | ₩3.03 Billion | ₩413.73 Billion | — |